Retinal Rejuvenation Therapy (2RT) is a non-thermal laser therapy that stimulates a natural, biological healing response in the eye. According to Ellex, a pilot study on 50 patients “demonstrated potential as an intervention which may positively influence early age-related macular degeneration (AMD). Clinical studies have also shown 2RT to be an effective treatment for Clinically Significant Macular Edema (CSME).
“In the pilot study 2RT has been shown to reduce the area and volume of drusen from a baseline of 5 per cent or more, and to deliver a functional improvement in some high risk early AMD patients.”
Ellex states that, “2RT protects the retina from thermal damage. It also offers the potential to apply treatment earlier in the disease process with the aim of slowing retinal degeneration, thereby eliminating or delaying the risk of vision threatening complications associated with the late-stage of retinal disease”.
Contact: Ellex Medical (AUS) 08 8104 5200
